IKZF1 and acute lymphoblastic leukemia: IKZF1 deletions and nonsense mutations identified at diagnosis are preserved at relapse [27] and may be used for highly sensitive MRD tests in addition to the repertoire of MRD markers currently available for monitoring MRD in ALL [32].